Finkelstein Thompson LLP Announces Investigation of Zenith National Insurance Corp.

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Zenith National Insurance Corp. (“Zenith” or the “Company”) (NYSE:ZNT) arising from the Company’s announcement of its intent to be acquired by Fairfax Financial Holdings Limited (“Fairfax”).

On February 18, 2010, Zenith announced that it entered into a merger agreement with Fairfax, in which Fairfax will purchase all common stock of the Company that it does not already own. Fairfax currently owns an 8.23% stake in Zenith. Under the terms of the agreement, Zenith shareholders will receive $38.00 in cash for every share of Zenith stock that they own in an all-cash transaction valued at approximately $1.4 billion. The deal is expected to close in the second quarter of 2010.

The investigation is focused on the potential unfairness of the price to Zenith shareholders, potential conflicts of interests on the part of the Zenith board and management, and whether the Zenith board took all appropriate steps to maximize shareholder value. Indeed, at least one analyst has set a price target for Zenith stock at $40.00 per share.

If you are interested in discussing your rights as a Zenith shareholder, or have information relating to this investigation, please contact Finkelstein Thompson's Washington, DC offices at (877) 337-1050 or by email at contact@finkelsteinthompson.com.

Finkelstein Thompson LLP has spent over three decades delivering outstanding representation to institutional and individual clients in financial litigation, and has been appointed as lead or co-lead counsel in dozens of shareholder class actions. Indeed, the firm has served in leadership roles in cases that have recovered over $1 billion for investors and consumers.

To learn more about Finkelstein Thompson LLP, please visit our web site at www.finkelsteinthompson.com. Attorney advertising. Prior results do not guarantee similar outcomes.

Zenith (NYSE:ZNT)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024